Drugs/Medical Legal News Articles & Interviews

Washington, DC On October 10, U.S. Senator Elizabeth Warren sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely review a proposed merger between Novo Nordisk and Catalent. Catalent is one of the very few suppliers that provide specialized development and manufacturing services to GLP-1 manufacturers. The letter urges the FTC to block the deal if it could hurt Americans by limiting competition and raising the price of life-saving medicine. Not coincidentally, killing competition might also limit the development of drugs without the dangerous side effects of Ozempic.

Santa Clara, CA The drug maker GSK agreed a few weeks ago to pay up to $2.2 billion to resolve Zantac lawsuits. The blockbuster heartburn drug, which was sold over-the-counter, was removed from the market in 2020 after the FDA ordered all ranitidine (the generic name) products withdrawn, citing unacceptable levels of the chemical N-nitroso dimethylamine (NDMA), a probable human carcinogen. 

Washington, DC Ozempic, a semaglutide, is a medication primarily used to treat type 2 diabetes. It works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. However, recent studies have revealed a surprising potential benefit: addiction reduction, specifically with reference to alcohol and opioid abuse.

 

Cleveland, OH In recent years, Suboxone, a critical medication used to treat opioid addiction, has come under fire for its unintended side effects—specifically, severe tooth decay. While the drug has helped millions overcome opioid dependence, patients across the country have filed dangerous drug lawsuits claiming that Suboxone caused serious dental problems, leading to painful and costly procedures as well as social isolation for some individuals. These claims have been consolidated in an ongoing multidistrict litigation (MDL) in the Northern District of Ohio, where patients are suing the manufacturers of Suboxone for failing to warn about the risk of tooth decay. 

Columbus, OH Becton, Dickinson and Company (BD), the parent company of BARD, has agreed to settle about 38,000 hernia mesh lawsuits. Reports indicate that the total payouts could exceed $1 Billion. The mesh lawsuits, some of which go back almost 20 years, allege that Bard designed defective mesh products, failed to adequately test them, and didn’t properly warn users about potential risks.

Santa Clara, CA Medical malpractice happens when a healthcare expert, via omission or negligent act, injures or causes harm to patients. If you suffer any harm or are injured because of a healthcare professional’s negligence, you’re entitled to compensation. However, your settlement amount primarily depends on how you handle your medical malpractice lawsuit. Discussed below are four tips for maximizing your compensation in a malpractice case.

Santa Clara, CA The first Exactech knee bellwether trials in multi-district litigation are slated for July and September 2025. At least 1,670 Exactech lawsuits are involved, blaming a packaging problem that caused hip, knee, shoulder and ankle implants to degrade and fail long before their time. Some patients required replacement surgery within a few years of receiving the implant.

Cleveland, OH As of September 2024, 674 lawsuits have been consolidated in the multidistrict Suboxone Film Productions liability litigation (MDL) in the Northern District of Ohio. These dangerous drug lawsuits allege that the sublingual film prescribed to treat opioid addiction also caused devastating tooth decay and long-term dental damage. For many patients, this led to costly treatments and a diminished quality of life.

 

Washington, DC On September 24, the Senate Committee on Health Education Labor and Pensions (HELP) will hear testimony from Lars Jorgensen, Novo Nordisk CEO, about why American consumers pay as much as ten times more for Ozempic and Wegovy than patients in the U.K. and the Netherlands. The popular diabetes and weight loss drugs have already been linked to serious side effects. These well-documented Ozempic side effects include stomach paralysis, a rare form of blindness, thyroid cancer and bowel obstruction.   

New York, NY On July 26, New York Attorney General, Letitia James announced that Suboxone manufacturer Indivior had agreed in principle to pay $86 million to settle Suboxone lawsuits brought by the attorneys general of New York, Illinois, Tennessee, Utah and Virginia. The settlement was reached in coordination with 11 other states. Their dangerous drug lawsuits alleged that Indivior produced and then marketed buprenorphine-based products to dangerous prescribers who, under the guise of “medical treatment,” triggered further harm.